Created at Source Raw Value Validated value
Oct. 31, 2020, 11:31 p.m. usa

- allergy to amide local anesthetics - acute porphyria - disorders of atrioventricular conduction requiring a non-done permanent electrosystolic pacing - uncontrolled epilepsy - fluvoxamine treatment - class iii antiarrythmic agent treatments (amiodarone, dronedarone) - class i antiarythmic agent (quinidine, disopyramide, hydroquinidine, flecainid, propafenone) - hepatocellular insufficiency defined by pt<15% in the absence of anti-vitamin k - patient under a tutelage measure or placed under judicial protection - known pregnancy - breastfeeding

- allergy to amide local anesthetics - acute porphyria - disorders of atrioventricular conduction requiring a non-done permanent electrosystolic pacing - uncontrolled epilepsy - fluvoxamine treatment - class iii antiarrythmic agent treatments (amiodarone, dronedarone) - class i antiarythmic agent (quinidine, disopyramide, hydroquinidine, flecainid, propafenone) - hepatocellular insufficiency defined by pt<15% in the absence of anti-vitamin k - patient under a tutelage measure or placed under judicial protection - known pregnancy - breastfeeding